not all positive

The announcement wasn't all good - They might be have got some extra cash for the next four years but what have they given up to get it?

The potential from age related macular degeneration (AMD) as well as DME treatment is immense. They have sold off this blue sky and keep only 20% of this. They have gone back to relying on Brachysil drug delivery and a smaller income stream from othphalmic drug delivery for their future. Unless they can come up with some other uses for their drug delievry systems such as heart drug delivery where is the Blue Sky potential - Pancreatic cancer via Brachysil?